CN110693795A - 含紫米花青素的护肤品及其制备方法 - Google Patents
含紫米花青素的护肤品及其制备方法 Download PDFInfo
- Publication number
- CN110693795A CN110693795A CN201911118427.0A CN201911118427A CN110693795A CN 110693795 A CN110693795 A CN 110693795A CN 201911118427 A CN201911118427 A CN 201911118427A CN 110693795 A CN110693795 A CN 110693795A
- Authority
- CN
- China
- Prior art keywords
- purple rice
- percent
- skin care
- anthocyanin
- care product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 97
- 235000009566 rice Nutrition 0.000 title claims abstract description 97
- 235000010208 anthocyanin Nutrition 0.000 title claims abstract description 75
- 229930002877 anthocyanin Natural products 0.000 title claims abstract description 75
- 239000004410 anthocyanin Substances 0.000 title claims abstract description 75
- 150000004636 anthocyanins Chemical class 0.000 title claims abstract description 75
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 96
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 57
- 229910001868 water Inorganic materials 0.000 claims abstract description 28
- 238000000605 extraction Methods 0.000 claims abstract description 14
- 239000008267 milk Substances 0.000 claims abstract description 14
- 210000004080 milk Anatomy 0.000 claims abstract description 14
- 235000013336 milk Nutrition 0.000 claims abstract description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 27
- 239000000047 product Substances 0.000 claims description 26
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 24
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 21
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 20
- 239000006228 supernatant Substances 0.000 claims description 20
- 230000001804 emulsifying effect Effects 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 238000002137 ultrasound extraction Methods 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 14
- 229910021641 deionized water Inorganic materials 0.000 claims description 14
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical group COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 13
- 229920002907 Guar gum Polymers 0.000 claims description 13
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 13
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 13
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 13
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 13
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- 239000000665 guar gum Substances 0.000 claims description 13
- 229960002154 guar gum Drugs 0.000 claims description 13
- 235000010417 guar gum Nutrition 0.000 claims description 13
- 229940119170 jojoba wax Drugs 0.000 claims description 13
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 13
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 13
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 13
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 13
- 229940032094 squalane Drugs 0.000 claims description 13
- 238000001816 cooling Methods 0.000 claims description 12
- 239000003755 preservative agent Substances 0.000 claims description 11
- 230000002335 preservative effect Effects 0.000 claims description 11
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 10
- 229960000458 allantoin Drugs 0.000 claims description 10
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 10
- 239000001630 malic acid Substances 0.000 claims description 10
- 235000011090 malic acid Nutrition 0.000 claims description 10
- 229920000223 polyglycerol Polymers 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 10
- 239000012752 auxiliary agent Substances 0.000 claims description 9
- 238000004945 emulsification Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 239000003205 fragrance Substances 0.000 claims description 7
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 7
- 229960002216 methylparaben Drugs 0.000 claims description 7
- 229920002545 silicone oil Polymers 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 claims description 6
- 241000208680 Hamamelis mollis Species 0.000 claims description 6
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 claims description 6
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 229960002510 mandelic acid Drugs 0.000 claims description 6
- 229940083037 simethicone Drugs 0.000 claims description 6
- 229940118846 witch hazel Drugs 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- 229930014669 anthocyanidin Natural products 0.000 claims description 5
- 235000008758 anthocyanidins Nutrition 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 229940106157 cellulase Drugs 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 5
- 230000010355 oscillation Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000002390 rotary evaporation Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 150000001453 anthocyanidins Chemical class 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 13
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 235000006708 antioxidants Nutrition 0.000 abstract description 6
- 108090000790 Enzymes Proteins 0.000 abstract description 5
- 102000004190 Enzymes Human genes 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract description 3
- 230000001934 delay Effects 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 abstract description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 238000002965 ELISA Methods 0.000 description 8
- 239000003642 reactive oxygen metabolite Substances 0.000 description 7
- BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 229910021642 ultra pure water Inorganic materials 0.000 description 6
- 239000012498 ultrapure water Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 4
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 4
- 244000133098 Echinacea angustifolia Species 0.000 description 3
- 229910021577 Iron(II) chloride Inorganic materials 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000014134 echinacea Nutrition 0.000 description 3
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 3
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000010975 amethyst Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- -1 oxygen free radical Chemical class 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/82—Preparation or application process involves sonication or ultrasonication
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及化妆品技术领域,具体涉及含紫米花青素的护肤品及其制备方法。所述含紫米花青素的护肤品中含有0.1‑10%重量百分比的紫米花青素,主要涉及的护肤品包括精华水和精华乳。本发明采用超声波‑酶法结合提取紫米中花青素,能有效提高紫米花青素的得率,能缩短提取时间,减少化学试剂提取对环境的污染。采用天然紫米花青素制备的抗氧化护肤品中不含有害的化学添加剂,可有效清除自由基、降低ROS水平、提高抗氧化酶活性,具有良好的抗衰作用,充分提高肌肤活力,改善肌肤暗沉现象,延缓衰老。
Description
技术领域
本发明涉及化妆品技术领域,具体涉及含紫米花青素的护肤品及其制备方法。
背景技术
随着现代科学的发展,对于肌肤衰老的众多学说中,活性氧自由基学说得到了广泛的认可。人体在正常的生理代谢过程中,受光照、粉尘、辐射、紫外线、空气污染、油炸食物及压力等影响会产生大量活性氧自由基(ROS)。而人体是一个平衡的状态,当ROS的积聚量无法与人体清除自由基的能力抵消的时候,平衡就会被打破。皮肤覆盖于我们全身,将人体内部与外界环境隔离开来,相当于在人体与外界环境之间的一道“屏障”,直接暴露于环境,是保护人体,维护人体内部环境的稳定和平衡的重要器官,更容易也更直观的反映出机体氧化损伤,表现为皮肤衰老或引发光老化、皮炎、皮肤肿瘤等疾病。
由于人体抗氧化机制不是一个独立的***,而是人体多种机制相互协调共同作用的结果。因此开发和使用具有抗氧化作用的护肤产品,直接作用于体表,可以达到延缓皮肤老化的效果,逐渐成为消费群体的主要需求。而目前,清除自由基、降低ROS水平、提高抗氧化酶活性等抗氧化效果的评价体系已得到广泛的认可和推广,寻求植物来源的天然产物,减少化学成分的使用,在健康安全的基础上获得抗氧化活性成分,已经逐渐成为设计开发抗衰老护肤品的一种开发热点。
紫米是一种珍贵的水稻品种,颗粒均匀,颜色紫黑,紫谷味甘、性温,有益气补血、暖胃健脾、滋补肝肾、缩小便、止咳喘等作用。紫谷的主要成分是赖氨酸、色氨酸、维生素B1、维生素B2、叶酸、蛋白质、脂肪等多种营养物质,以及铁、锌、钙、磷等人体所需矿物元素。除此之外,紫谷还富含花青素,花青素属于植物多酚中的类黄酮类物质,是广泛存在于自然界中的一类水溶性天然色素,具有抗氧化性、预防心脑血管疾病与癌症、保护肝脏与视力等功能,在食品、医药等方面都有重要的应用,但目前提取紫米花青素制备护肤品的研究尚未检索到。
发明内容
针对以上技术问题,本发明的目的是提供含紫米花青素的护肤品及其制备方法,通过提取紫米中天然花青素制备护肤品,能够活化细胞,清除自由基,具有较强的抗氧化活性,能够抵抗衰老,提高肌肤活力。
为了实现上述目的,本发明采用如下技术方案:
含紫米花青素的护肤品,所述护肤品中紫米花青素的含量为0.1-10%;
进一步地,所述紫米花青素的提取方法包括以下步骤:
(1)将紫米粉碎后过60-100目筛,干燥至水分含量低于10%,得到紫米粉末;
(2)在所述紫米粉末中加入HAc-NaAc缓冲溶液,将pH调至5.0,再加入所述紫米粉末总质量0.5-3.5%的纤维素酶,在40-65℃温度下水浴振荡酶解20-40min,得到混合初始料;
(3)酶解完成后在所述混合初始料中按料液比1:10-30加入纯净水,置于超声设备中进行超声提取,超声功率为300-500w,提取时间为20-40min,得到提取液;
(4)将所述提取液于3500-4500r/min下离心6-10min,分离上清液;在下层沉淀中按料液比1:10-20加入纯净水,在相同功率下超声提取10-20min,分离上清液;再次将下层沉淀中按料液比1:10-20加入纯净水,在相同功率下超声提取10min,分离上清液;合并所有上清液液并过滤,置于旋转蒸发仪中蒸发浓缩至恒重,旋蒸温度为40℃,即得到所述紫米花青素。
优选地,所述护肤品为精华水,包括以下重量配比的成分:组分A包括丁二醇1-5%、紫米花青素0.1-10%和辅料0.1-5%;组分B包括1,2-戊二醇2-10%、甘油1-5%、透明质酸钠0.1-1%、苹果酸0.1-0.3%和尿囊素0.1-0.2%;组分C包括香精、防腐剂0.3-0.5%和香精增溶剂0.1-0.5%;余量为去离子水。
进一步地,所述辅料为VE、金缕梅提取物、杏仁酸中的一种或多种;所述防腐剂为尼泊金甲酯;所述香精增溶剂为CO-40。
优选地,所述精华水包括以下重量配比的成分:组分A包括丁二醇1-5%、紫米花青素0.1-1%、VE0.1-1%、金缕梅提取物0.5-2%和杏仁酸0.5-2%;组分B包括1,2-戊二醇2-10%、甘油1-5%、透明质酸钠0.1-1%、苹果酸0.1-0.3%和尿囊素0.1-0.2%;组分C包括香精、尼泊金甲酯0.3-0.5%和CO-40 0.1-0.5%;余量为去离子水。
进一步地,所述含紫米花青素的精华水的制备方法包括以下步骤:
(1)按照上述重量配比,将1,2-戊二醇和透明质酸钠预混合均匀;将水、甘油、苹果酸和尿囊素放入乳化罐中搅拌均匀,放入预混合好的1,2-戊二醇和透明质酸钠进行搅拌,加热至75-85℃溶解完全;
(2)降温至48-55℃,加入预混合好的丁二醇、紫米花青素和辅料,搅拌分散均匀;
(3)降温至35-42℃时加入防腐剂、预混合好的香精和香精增溶剂,搅拌均匀后过滤密封包装,即得含有紫米花青素的精华水。
优选地,所述护肤品为精华乳,包括以下重量配比的成分:组分A包含荷荷巴油0.5-5%、角鲨烷1-3%、乳化剂1.2-3%和二甲基硅油2-3%;组分B包含丁二醇5-10%、聚甘油醚-26 2-5%、三乙醇胺0.1-0.2%和瓜尔豆胶0.03-0.05%;组分C包含紫米花青素0.1-10%、VC0.1-0.5%、海藻糖0.5-1%和乳化助剂0.5-1%;组分D包含香精和防腐剂;余量为去离子水。
优选地,所述精华乳包括以下重量配比的成分:组分A包含荷荷巴油3%、角鲨烷2%、乳化剂3%和二甲基硅油2%;组分B包含丁二醇8%、聚甘油醚-263%、三乙醇胺0.1%和瓜尔豆胶0.03%;组分C包含紫米花青素0.1-1%、VC0.3%、海藻糖0.7%和乳化助剂0.7%;组分D包含香精和防腐剂;余量为去离子水。
进一步地,所述含紫米花青素的精华乳的制备方法包括以下步骤:
(1)将紫米花青素、VC、海藻糖和乳化助剂在40-42℃预先混合好;
(2)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油与丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶分别加热升温至85-90℃,搅拌均匀至完全溶解;
(3)将丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶放入乳化罐中,保持85-90℃搅拌混合均匀;
(4)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油慢慢加入乳化罐中,并以搅拌10-15min与步骤(3)的混合物混合均匀;
(5)将乳化罐中的料液降温至40-42℃时加入预先混合好的紫米花青素、VC、海藻糖和乳化助剂,继续搅拌均匀;
(6)降温至35-38℃时加入香精和防腐剂,搅拌均匀即可制得含有紫米花青素的精华乳。
与现有技术相比,本发明具有如下有益效果:
本发明采用超声波-酶法结合提取紫米中花青素,能有效提高紫米花青素的得率,能缩短提取时间,减少化学试剂提取对环境的污染。采用天然紫米花青素制备的抗氧化护肤品中不含有害的化学添加剂,可有效清除自由基、降低ROS水平、提高抗氧化酶活性,具有良好的抗衰作用,充分提高肌肤活力,改善肌肤暗沉现象,延缓衰老。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
以下实施例中所使用的物质均可自常规方式购买得到。
实施例1-1紫米花青素的提取
紫米花青素的提取方法包括以下步骤:
(1)将紫米粉碎后过60-100目筛,干燥至水分含量低于10%,得到紫米粉末;
(2)在所述紫米粉末中加入HAc-NaAc缓冲溶液,将pH调至5.0,再加入所述紫米粉末总质量0.5%的纤维素酶,在40℃温度下水浴振荡酶解40min,得到混合初始料;
(3)酶解完成后在所述混合初始料中按料液比1:10加入纯净水,置于超声设备中进行超声提取,超声功率为300w,提取时间为40min,得到提取液;
(4)将所述提取液于3500r/min下离心10min,分离上清液;在下层沉淀中按料液比1:10加入纯净水,在相同功率下超声提取10min,分离上清液;再次将下层沉淀中按料液比1:10加入纯净水,在相同功率下超声提取10min,分离上清液;合并所有上清液液并过滤,置于旋转蒸发仪中蒸发浓缩至恒重,旋蒸温度为40℃,即得到所述紫米花青素。
实施例1-2紫米花青素的提取
紫米花青素的提取方法包括以下步骤:
(1)将紫米粉碎后过60-100目筛,干燥至水分含量低于10%,得到紫米粉末;
(2)在所述紫米粉末中加入HAc-NaAc缓冲溶液,将pH调至5.0,再加入所述紫米粉末总质量2.0%的纤维素酶,在55℃温度下水浴振荡酶解30min,得到混合初始料;
(3)酶解完成后在所述混合初始料中按料液比1:20加入纯净水,置于超声设备中进行超声提取,超声功率为400w,提取时间为30min,得到提取液;
(4)将所述提取液于4000r/min下离心8min,分离上清液;在下层沉淀中按料液比1:20加入纯净水,在相同功率下超声提取20min,分离上清液;再次将下层沉淀中按料液比1:20加入纯净水,在相同功率下超声提取10min,分离上清液;合并所有上清液液并过滤,置于旋转蒸发仪中蒸发浓缩至恒重,旋蒸温度为40℃,即得到所述紫米花青素。
实施例1-3紫米花青素的提取
紫米花青素的提取方法包括以下步骤:
(1)将紫米粉碎后过60-100目筛,干燥至水分含量低于10%,得到紫米粉末;
(2)在所述紫米粉末中加入HAc-NaAc缓冲溶液,将pH调至5.0,再加入所述紫米粉末总质量3.5%的纤维素酶,在65℃温度下水浴振荡酶解20min,得到混合初始料;
(3)酶解完成后在所述混合初始料中按料液比1:30加入纯净水,置于超声设备中进行超声提取,超声功率为500w,提取时间为20min,得到提取液;
(4)将所述提取液于4500r/min下离心6min,分离上清液;在下层沉淀中按料液比1:10加入纯净水,在相同功率下超声提取20min,分离上清液;再次将下层沉淀中按料液比1:10加入纯净水,在相同功率下超声提取10min,分离上清液;合并所有上清液液并过滤,置于旋转蒸发仪中蒸发浓缩至恒重,旋蒸温度为40℃,即得到所述紫米花青素。
实施例2-1含紫米花青素的精华水
所述含紫米花青素的精华水包括以下重量配比的成分:组分A包括丁二醇5%、紫米花青素10%和VE 0.1%;组分B包括1,2-戊二醇2%、甘油5%、透明质酸钠0.1%、苹果酸0.1%和尿囊素0.2%;组分C包括香精、尼泊金甲酯0.5%和CO-40 0.1%;余量为去离子水。
实施例2-2含紫米花青素的精华水
所述含紫米花青素的精华水包括以下重量配比的成分:组分A包括丁二醇3%、紫米花青素1%、金缕梅提取物0.5%和杏仁酸0.5%;组分B包括1,2-戊二醇5%、甘油3%、透明质酸钠0.5%、苹果酸0.2%和尿囊素0.15%;组分C包括香精、尼泊金甲酯0.4%和CO-400.3%;余量为去离子水。
实施例2-3含紫米花青素的精华水
所述含紫米花青素的精华水包括以下重量配比的成分:组分A包括丁二醇1%、紫米花青素0.1%、VE1%、金缕梅提取物2%和杏仁酸2%;组分B包括1,2-戊二醇10%、甘油1%、透明质酸钠1%、苹果酸0.3%和尿囊素0.1%;组分C包括香精、尼泊金甲酯0.3和CO-400.5%;余量为去离子水。
实施例2-4含紫米花青素的精华水的制备方法
制备方法包括以下步骤:
(1)按照上述重量配比,将1,2-戊二醇和透明质酸钠预混合均匀;将水、甘油、苹果酸和尿囊素放入乳化罐中搅拌均匀,放入预混合好的1,2-戊二醇和透明质酸钠进行搅拌,加热至75-85℃溶解完全;
(2)降温至48-55℃,加入预混合好的丁二醇、紫米花青素和辅料,搅拌分散均匀;
(3)降温至35-42℃时加入防腐剂、预混合好的香精和香精增溶剂,搅拌均匀后过滤密封包装,即得含有紫米花青素的精华水。
实施例3-1含紫米花青素的精华乳
所述含紫米花青素的精华乳包括以下重量配比的成分:组分A包含荷荷巴油0.5%、角鲨烷3%、乳化剂1.2%和二甲基硅油3%;组分B包含丁二醇5%、聚甘油醚-265%、三乙醇胺0.15%和瓜尔豆胶0.04%;组分C包含紫米花青素10%、VC0.1%、海藻糖0.5%和乳化助剂1%;组分D包含香精和防腐剂;余量为去离子水。
实施例3-2含紫米花青素的精华乳
所述含紫米花青素的精华乳包括以下重量配比的成分:组分A包含荷荷巴油3%、角鲨烷2%、乳化剂3%和二甲基硅油2%;组分B包含丁二醇8%、聚甘油醚-26 3%、三乙醇胺0.1%和瓜尔豆胶0.03%;组分C包含紫米花青素1%、VC0.3%、海藻糖0.7%和乳化助剂0.7%;组分D包含香精和防腐剂;余量为去离子水。
实施例3-3含紫米花青素的精华乳
所述含紫米花青素的精华乳包括以下重量配比的成分:组分A包含荷荷巴油5%、角鲨烷1%、乳化剂2%和二甲基硅油2.5%;组分B包含丁二醇10%、聚甘油醚-26 2%、三乙醇胺0.2%和瓜尔豆胶0.05%;组分C包含紫米花青素0.1%、VC0.5%、海藻糖1%和乳化助剂0.5%;组分D包含香精和防腐剂;余量为去离子水。
实施例3-4含紫米花青素的精华乳的制备方法
制备方法包括以下步骤:
(1)将紫米花青素、VC、海藻糖和乳化助剂在40-42℃预先混合好;
(2)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油与丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶分别加热升温至85-90℃,搅拌均匀至完全溶解;
(3)将丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶放入乳化罐中,保持85-90℃搅拌混合均匀;
(4)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油慢慢加入乳化罐中,并以搅拌10-15min与步骤(3)的混合物混合均匀;
(5)将乳化罐中的料液降温至40-42℃时加入预先混合好的紫米花青素、VC、海藻糖和乳化助剂,继续搅拌均匀;
(6)降温至35-38℃时加入香精和防腐剂,搅拌均匀即可制得含有紫米花青素的精华乳。
实验例1DPPH清除率测试
1.试验材料:无水乙醇,分析纯;1,1-二苯基-2-三硝基苯肼(DPPH);二甲基亚砜(DMSO);
2.试验主要仪器:Varioskan Flash酶标仪;Milli-Q超纯水;紫外可见分光光度计(TU-1810);Brand移液器;96孔酶标板;
3.阳性对照药:VC溶液;
4.试验步骤:准确称取20mg DPPH,用无水乙醇定容至250mL,得到浓度为2×10-4mol/L的DPPH溶液。利用DPPH溶液的特征***团517nm的吸收峰,用酶标仪测定加入测试物后A517吸收的下降表示其对有机自由基的清除能力,将测试样品稀释至不同浓度,于96孔酶标板中,加入190μL DPPH和10μL样品,反应总体积200μL。空白对照组为190μL DPPH+10μL DMSO,混合均匀后锡纸包好避光振摇反应30min,测定517nm波长下吸光值的变化;
5.数据处理:按照下列公式进行计算抗氧化物质的抑制率,
抑制率%=[1-([DPPH·]t/[DPPH·]t=0)]×100%,
式中:[DPPH·]t=0——空白体系中1,1-二苯基-2-三硝基苯肼自由基的起始浓度,
[DPPH·]t——加入待测试药物后1,1-二苯基-2-三硝基苯肼自由基的浓度。
测得结果如表1所示,本发明制备的含紫米花青素的精华水和精华乳与阳性对照VC比较有显著的抗氧化作用。
表1DPPH清除率结果
实验例2羟基自由基清除率测试
1.试验材料:PH 7.4、0.2mol/L的磷酸缓冲液;邻二氮菲5.0mmol/L;二甲基亚砜(DMSO);FeCl2;H2O2;
2.试验主要仪器:Varioskan Flash酶标仪;Milli-Q超纯水;紫外可见分光光度计(TU-1810);Brand移液器;96孔酶标板;恒温水浴装置;
3.阳性对照药:VC溶液。
4.试验步骤:取40μL PH 7.4、0.2mol/L的磷酸缓冲液和160μL超纯水作为空白;取40μL磷酸缓冲液、30μL的邻二氮菲、30μL FeCl2(7.5mmol/L)和110μL超纯水作为A未损;取40μL磷酸缓冲液、30μL的邻二氮菲、20μL FeCl2、90μL超纯水和20μL的VC溶液(0.1%)作为A损伤;取40μL磷酸缓冲液、30μL的邻二氮菲、20μL FeCl2、80μL超纯水、10μL不同浓度的药物,20μL的VC溶液作为A样品,反应的总体积为200μL,将上述各组样品摇匀后置于恒温水槽中,37℃保温60min,置于波长510nm处,测吸光度(A)值。
5.数据处理:按照下列公式进行计算羟基自由基的清除率:
羟基自由基清除率=[(A样品-A损伤)/(A未损-A损伤)]×100%;
测得结果如表2所示,本发明制备的含紫米花青素的精华水和精华乳对羟基自由基的清除效果明显。
表2羟基自由基清除率结果
综上所述,本发明采用天然紫米花青素制备的抗氧化护肤品中不含有害的化学添加剂,可有效清除自由基、降低ROS水平、提高抗氧化酶活性,具有良好的抗衰作用,充分提高肌肤活力,改善肌肤暗沉现象,延缓衰老。
Claims (8)
1.含紫米花青素的护肤品,其特征在于,所述护肤品中紫米花青素的含量为0.1-10%;
所述紫米花青素的提取方法包括以下步骤:
(1)将紫米粉碎后过60-100目筛,干燥至水分含量低于10%,得到紫米粉末;
(2)在所述紫米粉末中加入HAc-NaAc缓冲溶液,将pH调至5.0,再加入所述紫米粉末总质量0.5-3.5%的纤维素酶,在40-65℃温度下水浴振荡酶解20-40min,得到混合初始料;
(3)酶解完成后在所述混合初始料中按料液比1:10-30加入纯净水,置于超声设备中进行超声提取,超声功率为300-500w,提取时间为20-40min,得到提取液;
(4)将所述提取液于3500-4500r/min下离心6-10min,分离上清液;在下层沉淀中按料液比1:10-20加入纯净水,在相同功率下超声提取10-20min,分离上清液;再次将下层沉淀中按料液比1:10-20加入纯净水,在相同功率下超声提取10min,分离上清液;合并所有上清液液并过滤,置于旋转蒸发仪中蒸发浓缩至恒重,旋蒸温度为40℃,即得到所述紫米花青素。
2.根据权利要求1所述的含紫米花青素的护肤品,其特征在于,所述护肤品为精华水,包括以下重量配比的成分:组分A包括丁二醇1-5%、紫米花青素0.1-10%和辅料0.1-5%;组分B包括1,2-戊二醇2-10%、甘油1-5%、透明质酸钠0.1-1%、苹果酸0.1-0.3%和尿囊素0.1-0.2%;组分C包括香精、防腐剂0.3-0.5%和香精增溶剂0.1-0.5%;余量为去离子水。
3.根据权利要求2所述的含紫米花青素的护肤品,其特征在于,所述辅料为VE、金缕梅提取物、杏仁酸中的一种或多种;所述防腐剂为尼泊金甲酯;所述香精增溶剂为CO-40。
4.根据权利要求2或3所述的含紫米花青素的护肤品,其特征在于,包括以下重量配比的成分:组分A包括丁二醇1-5%、紫米花青素0.1-1%、VE0.1-1%、金缕梅提取物0.5-2%和杏仁酸0.5-2%;组分B包括1,2-戊二醇2-10%、甘油1-5%、透明质酸钠0.1-1%、苹果酸0.1-0.3%和尿囊素0.1-0.2%;组分C包括香精、尼泊金甲酯0.3-0.5%和CO-40 0.1-0.5%;余量为去离子水。
5.根据权利要求2或3所述的含紫米花青素的护肤品,其特征在于,所述含紫米花青素的护肤品的制备方法包括以下步骤:
(1)按照上述重量配比,将1,2-戊二醇和透明质酸钠预混合均匀;将水、甘油、苹果酸和尿囊素放入乳化罐中搅拌均匀,放入预混合好的1,2-戊二醇和透明质酸钠进行搅拌,加热至75-85℃溶解完全;
(2)降温至48-55℃,加入预混合好的丁二醇、紫米花青素和辅料,搅拌分散均匀;
(3)降温至35-42℃时加入防腐剂、预混合好的香精和香精增溶剂,搅拌均匀后过滤密封包装,即得含有紫米花青素的精华水。
6.根据权利要求1所述的含紫米花青素的护肤品,其特征在于,所述护肤品为精华乳,包括以下重量配比的成分:组分A包含荷荷巴油0.5-5%、角鲨烷1-3%、乳化剂1.2-3%和二甲基硅油2-3%;组分B包含丁二醇5-10%、聚甘油醚-26 2-5%、三乙醇胺0.1-0.2%和瓜尔豆胶0.03-0.05%;组分C包含紫米花青素0.1-10%、VC0.1-0.5%、海藻糖0.5-1%和乳化助剂0.5-1%;组分D包含香精和防腐剂;余量为去离子水。
7.根据权利要求6所述的含紫米花青素的护肤品,其特征在于,包括以下重量配比的成分:组分A包含荷荷巴油3%、角鲨烷2%、乳化剂3%和二甲基硅油2%;组分B包含丁二醇8%、聚甘油醚-26 3%、三乙醇胺0.1%和瓜尔豆胶0.03%;组分C包含紫米花青素0.1-1%、VC0.3%、海藻糖0.7%和乳化助剂0.7%;组分D包含香精和防腐剂;余量为去离子水。
8.根据权利要求6或7所述的含紫米花青素的护肤品,其特征在于,所述含紫米花青素的护肤品的制备方法包括以下步骤:
(1)将紫米花青素、VC、海藻糖和乳化助剂在40-42℃预先混合好;
(2)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油与丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶分别加热升温至85-90℃,搅拌均匀至完全溶解;
(3)将丁二醇、聚甘油醚-26、三乙醇胺和瓜尔豆胶放入乳化罐中,保持85-90℃搅拌混合均匀;
(4)将荷荷巴油、角鲨烷、乳化剂和二甲基硅油慢慢加入乳化罐中,并以搅拌10-15min与步骤(3)的混合物混合均匀;
(5)将乳化罐中的料液降温至40-42℃时加入预先混合好的紫米花青素、VC、海藻糖和乳化助剂,继续搅拌均匀;
(6)降温至35-38℃时加入香精和防腐剂,搅拌均匀即可制得含有紫米花青素的精华乳。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911118427.0A CN110693795A (zh) | 2019-11-15 | 2019-11-15 | 含紫米花青素的护肤品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911118427.0A CN110693795A (zh) | 2019-11-15 | 2019-11-15 | 含紫米花青素的护肤品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693795A true CN110693795A (zh) | 2020-01-17 |
Family
ID=69206217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911118427.0A Pending CN110693795A (zh) | 2019-11-15 | 2019-11-15 | 含紫米花青素的护肤品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693795A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113876675A (zh) * | 2021-10-20 | 2022-01-04 | 广州市澳源科技集团有限公司 | 一种含紫米葡萄成分的发酵组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10287525A (ja) * | 1997-02-11 | 1998-10-27 | Pure:Kk | 化粧品、食品および入浴剤 |
JP2004099578A (ja) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
TW201318646A (zh) * | 2011-11-08 | 2013-05-16 | Univ Chienkuo Technology | 具皮膚美白之紫米花青素凝膠劑及其製備方法 |
CN106632205A (zh) * | 2016-10-09 | 2017-05-10 | 田珩 | 一种从云南松树皮中提取原花青素的方法 |
CN108403574A (zh) * | 2018-06-08 | 2018-08-17 | 桃源县兴隆米业科技开发有限公司 | 一种基于紫米提取液美白保湿面膜的制备方法 |
-
2019
- 2019-11-15 CN CN201911118427.0A patent/CN110693795A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10287525A (ja) * | 1997-02-11 | 1998-10-27 | Pure:Kk | 化粧品、食品および入浴剤 |
JP2004099578A (ja) * | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
TW201318646A (zh) * | 2011-11-08 | 2013-05-16 | Univ Chienkuo Technology | 具皮膚美白之紫米花青素凝膠劑及其製備方法 |
CN106632205A (zh) * | 2016-10-09 | 2017-05-10 | 田珩 | 一种从云南松树皮中提取原花青素的方法 |
CN108403574A (zh) * | 2018-06-08 | 2018-08-17 | 桃源县兴隆米业科技开发有限公司 | 一种基于紫米提取液美白保湿面膜的制备方法 |
Non-Patent Citations (2)
Title |
---|
刘强: "花青素提取工艺的研究进展" * |
张文彦等: "云南墨江紫米花青素抗氧化活性的研究" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113876675A (zh) * | 2021-10-20 | 2022-01-04 | 广州市澳源科技集团有限公司 | 一种含紫米葡萄成分的发酵组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105997754A (zh) | 一种山茶花提取液及其制备方法与应用 | |
CN111481481B (zh) | 一种金丝***纳米技术护肤品及其制备方法和应用 | |
CN101336874A (zh) | 果皮中水溶性活性提取物及制备方法和用途 | |
CN107362084A (zh) | 一种含有盐肤木叶提取物的面膜及其制备方法 | |
CN111407678A (zh) | 一种具有保湿亮肤抗衰功效的微乳液及其制备方法 | |
CN111514072B (zh) | 一种牛大力-诺丽复合酵素及其制备方法与在制备面膜中的应用 | |
CN102525838A (zh) | 一种复合多糖类保湿护肤剂及其制备方法 | |
KR20170132388A (ko) | 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부미백용 조성물 | |
CN105919889A (zh) | 一种青刺果发酵原浆化妆品及其制备方法与应用 | |
CN111297756B (zh) | 一种具有滋润保湿、抗敏功效的精华液及其制备方法 | |
Syarifah et al. | Formulation and Antioxidant Activity of Serum Gel of Ethyl Acetate Fraction From Musa x paradisiaca L. | |
CN105287332B (zh) | 一种包含花萃多肽的美白保湿组合物、制备方法及应用 | |
CN110693795A (zh) | 含紫米花青素的护肤品及其制备方法 | |
CN107496284B (zh) | 一种天然复合植物紫外吸收剂及其应用 | |
CN111714423B (zh) | 一种具有抗衰舒敏功效的中药组合提取物及其制备方法和应用 | |
KR20110068949A (ko) | 매실나무 추출물 및 그 제조방법과 용도 | |
CN110200880B (zh) | 一种组合物及其在制备抗氧化的产品中的应用 | |
CN107049879A (zh) | 一种含有黄秋葵提取液的膏霜 | |
CN111603404A (zh) | 一种含细胞提取液的护肤精华液及其制备方法 | |
Ginting et al. | Utilization of Ambon Banana Stem (Musa paradisiaca var. sapientum (L)) Ethanol Extract as Moisturizing Sheet Mask | |
KR102373819B1 (ko) | 항산화 화장품 및 이의 제조 방법 | |
Amornlerdpison et al. | Antioxidant activity of Padina minor Yamada | |
CN115778887B (zh) | 一种美白防晒功效组合物及其制备方法 | |
CN117883352B (zh) | 一种紧致抗皱组合物及其应用 | |
CN110251434A (zh) | 百香果叶提取物在化妆品和保健品中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200117 |